Nitrous oxide (N2O) and subsequent open-label SSRI treatment of adolescents with depression (NOTAD): study protocol for a randomised controlled trial

Abstract Background The first line of pharmacological treatment for severe depressive disorders in young people is selective serotonin reuptake inhibitors (SSRIs). However, beneficial clinical effects are rarely observed before several weeks into treatment. Nitrous oxide (N2O) has a long-standing sa...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Richard M. Stewart, Janice W. Y. Wong, Kevin C. Runions, Pradeep Rao, Julia K. Moore, Simon R. Davies, Britta S. von Ungern-Sternberg, David Sommerfield, Florian Daniel Zepf
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2017-12-01
Edice:	Trials
Témata:	Depression Children Adolescents Nitrous oxide NMDA Psychopharmacology
On-line přístup:	http://link.springer.com/article/10.1186/s13063-017-2342-4
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!